)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
CNS Pharmaceuticals
CNS Pharmaceuticals (CNSP) investor relations material
CNS Pharmaceuticals Investor presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Investor presentation summary22 Apr, 2026
Strategic transformation and leadership
New executive team with deep expertise in neurology, oncology, and rare diseases is leading a strategic pivot to reposition for long-term growth.
Leadership includes proven track records in scaling organizations, advancing clinical programs, and executing strategic transactions.
Lean operating structure and disciplined capital allocation are central to the new strategy.
Focus on high-value neurology and oncology markets
Refocused on neurology and oncology, targeting large, growing markets with significant unmet needs and strong commercial viability.
Neurology and oncology together represent nearly 50% of investment and deal flow in the sector.
Oncology therapeutics market projected to exceed $400B over the next decade; neurology market exceeds $138B.
Asset acquisition and development strategy
Formal asset search underway, targeting novel, differentiated clinical-stage programs with clear biological rationale and near-term catalysts.
Diligence process includes market assessment, differentiation analysis, and risk mapping to identify assets with strong value creation potential.
Legacy programs are being positioned for out-licensing to unlock non-dilutive upside.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from CNS Pharmaceuticals
- Strategic shift to neurology and oncology drives higher R&D costs and ongoing going concern risk.CNSP
Q4 202531 Mar 2026 - TPI 287 was in-licensed, showing strong GBM efficacy and will enter pivotal trials in 2025.CNSPInvestor Update2 Feb 2026
- Pivotal brain cancer trial nears data, with new pipeline asset and strong financial footing.CNSPVirtual Investor CEO Connect23 Jan 2026
- Pivotal Berubicin data expected H1 2025; TPI-287 to enter glioblastoma trials in 2025.CNSPH.C. Wainwright 26th Annual Global Investment Conference 202421 Jan 2026
- Pivotal Berubicin trial in glioblastoma fully enrolled; top-line data expected Q1 2025.CNSPMaxim Group’s 2024 Healthcare Virtual Summit19 Jan 2026
- Berubicin’s pivotal GBM trial is fully enrolled, with data expected in early 2025.CNSPInvestor Update11 Jan 2026
- Key votes include director elections, share authorization increase, and equity plan amendments.CNSPProxy Filing2 Dec 2025
- Vote on reverse stock split, warrant repricing, and meeting adjournment to support NASDAQ compliance.CNSPProxy Filing2 Dec 2025
- Key votes on reverse stock split and warrant repricing aim to preserve Nasdaq listing and capital access.CNSPProxy Filing2 Dec 2025
Next CNS Pharmaceuticals earnings date
Q1 202621 May, 2026
CNS Pharmaceuticals
Next CNS Pharmaceuticals earnings date
Q1 202621 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage